ZELTIQ is a leading player in the cosmetic industry, particularly with its innovative treatment CoolSculpting, which has recently been acquired by Allergan PLC. Founded in 2005, the company operates in various therapeutic categories and is now part of Allergan PLC, a renowned global pharmaceutical company (NYSE: AGN) that focuses on branded pharmaceuticals and biologic products. With a presence in around 100 countries, Allergan is committed to delivering novel treatments for a range of medical needs, including those related to the central nervous system, eye care, medical aesthetics, dermatology, gastroenterology, women's health, urology, anti-infective, and cardiovascular fields. This strategic acquisition is poised to further strengthen Allergan's position in the industry and enhance its offerings.
There is no investment information
No recent news or press coverage available for ZELTIQ.
We care about your data, and we'd love to use cookies make your experience better.
